Cost-Effectiveness Analysis of Herpes Zoster Vaccination In Hong Kong

Herpes zoster (HZ), caused by reactivation of varicella zoster virus, is characterized by dermatome-based rash and severe pain. Post-herpetic neuralgia may occur following HZ. The risk of HZ increases with older age and reduced immunity. HZ vaccine has been first approved for adults aged 60 years and above, and recently approved for 50 years and above. The aim of present study was to evaluate the cost-effectiveness of implementing HZ vaccination program for adults at age 50 years versus 60 years in Hong Kong from the perspective of society.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: C Lee, J You Source Type: research